Sanofi Admelog insulin vial recall: Risk of contamination due to seal failure
Sanofi recalls Admelog insulin vials with malformed crimped collar seals that could lead to contamination. Affected vials have NDC 0024-5926-05 and lot # 3F497B, expiring Dec 2025.
Recall notice
Lack of Assurance of Sterility: Malformed crimped collar seal
Contact the company
What happened, in plain English
Sanofi is recalling Admelog insulin vials that may have a malformed crimped collar seal, which could allow contamination. This recall affects people using insulin injections and requires immediate action to prevent potential infection. Read more at govinfonow.com/recall/33735-sanofi-admelog-insulin-vial-recall-risk-of-contamination-due-to.
Source Summary by GovInfoNow · govinfonow.com/recall/33735-sanofi-admelog-insulin-vial-recall-risk-of-contamination-due-to · Updated August 17, 2026 · FDA enforcement record: FDA #D-0575-2023
Cite this page
“Sanofi Admelog insulin vial recall: Risk of contamination due to seal failure.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33735-sanofi-admelog-insulin-vial-recall-risk-of-contamination-due-to. Based on FDA recall #D-0575-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0575-2023%22&limit=1).
Why it’s dangerous
The vial's crimped collar seal may be malformed, creating a gap that could allow contaminants to enter the insulin. This could lead to infection if the vial is used after the seal fails.
Who’s affected
People with diabetes who use Admelog insulin vials are affected. Those using the recalled vials are at risk of contamination if the seal fails.
How to tell if you have this one
Check for NDC code 0024-5926-05 and lot number 3F497B on the vial label. The vials expire December 2025.
- Brand
Sanofi- Category
Drug
What to do — step by step
Check Vial Label
Look for NDC 0024-5926-05 and lot # 3F497B on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 43 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0575-2023 (April 11, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0575-2023 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.